Acute Coronary Syndrome
Conditions
Interventions
None listed
Sponsors
Society of ACS Intervention and Therapeutics
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Define ACS (Acute coronary syndrome) as UA (unstable angina), NSTEMI (Non-ST Elevation Myocardial Infarction) and STEMI (ST Elevation Myocardial Infarction). AMI have an onset within 24 hours and meet the criteria "Universal Definition of Myocardial Infarction" defined by ESC/ACCF/AHA/WHF task force. A)Having a diagnosis of any ACS symptom B)De-novo lesion in a target vessel C)Indication for PCI D)PROMUS stent should be used with on-label use or physician assesses PROMUS stent is an appropriate device for the patient. E)Should be deployed PROMUS stent.
Exclusion criteria
Exclusion criteria: F)Enrolled in another study (excluding PMS) or receiving any treatment affected the registry. G)Pregnant or possibility of pregnancy in the registry period. H)Known hypersensitivity reaction to everolimus, polymer, metal I)Known hypersensitivity reaction to antiplatelet J)Improper functioning of the liver K)Kidney malfunction(>=3.0mg/dl serum creatinine level) or dialysis treatment. L)Active cancer M)Lesion in saphenous vein graft N)cardiogenic shock by clinical assessment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major adverse cardiac event including cardiac death, myocardial infarction, and target lesion revascularization at 12 mont | — |
Secondary
| Measure | Time frame |
|---|---|
| TLR at 9 month/24 month TVR at 9 month/24month MI at 9 month/24 month Death at 9 month/24 month MACE at 9 month/24 month Stent thrombosis (acute, sub-acute, late, and very late) defined by Academic Research Consortium (ARC) at 9 month/ 24 month | — |
Countries
Japan
Contacts
Public ContactYoshinori Yasaka
Hyogo Brain and Heart Center Cardiology
Outcome results
None listed